GDOC.US Goldman Sachs Future Health Care Equity ETF
- Total assets
- 20.7M
- Expense ratio
- 0.72%
- Dividend yield
- 0.30%
- 1-year return
- +10.12%
- Holdings
- 40
- Since
- 2021
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does GDOC.US invest in?
- Mostly US stocks (87.9%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (91.3%)
- Top 3 holdings: 26.4% of the fund
Asset allocation
- US stocks 87.9%
- Non-US stocks 10.5%
- Cash 1.5%
Top holdings
- Eli Lilly and Company 14.42%
- Johnson & Johnson 6.00%
- UnitedHealth Group Incorporated 5.97%
- Merck & Company Inc 5.10%
- Edwards Lifesciences Corp 4.57%
Goldman Sachs Future Health Care Equity ETF performance
Sharpe ratio 0.55- This year
- +10.87%
- 1 year
- +10.12%
- 3 years
- +11.92%
- 5 years
- +0.44%
Volatility 15.5% over 1 year and 14.9% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
GDOC.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Goldman Sachs Future Health Care Equity ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and dig…
Full fund profileGoldman Sachs Future Health Care Equity ETF top holdings
54.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 14.42% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 6.00% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 5.97% |
| Merck & Company Inc MRK.US | Healthcare | United States | 5.10% |
| Edwards Lifesciences Corp EW.US | Healthcare | United States | 4.57% |
| Agilent Technologies Inc A.US | Healthcare | United States | 3.92% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.80% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 3.70% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 3.54% |
| Guardant Health Inc GH.US | Healthcare | United States | 3.32% |
The 10 largest of 40 holdings.
GDOC.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
GDOC.US regional exposure
- North America91.3%
- United Kingdom6.0%
- Europe Developed4.4%
Share of the stocks in the fund.
Company size
Average market cap 123B- Mega cap17.1%
- Big cap40.5%
- Medium cap32.0%
- Small cap8.9%
Goldman Sachs Future Health Care Equity ETF fund profile
- Fund name
- Goldman Sachs Future Health Care Equity ETF
- Ticker
- GDOC.US
- Exchange
- USA Stocks
- Issuer
- Goldman Sachs
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Nov 9, 2021
- Trading currency
- USD
- Expense ratio
- 0.72%
- Annual turnover
- 0.3%
About Goldman Sachs Future Health Care Equity ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non-U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.